Hackensack, NJNCT06939036Now EnrollingIRB Ready

Small Cell Lung Cancer Clinical Trial in Hackensack, NJ

Access cutting-edge small cell lung cancer treatment through this clinical trial at a research site in Hackensack. Study-provided care at no cost to qualified participants.

Sponsored by Ariceum Therapeutics GmbH

Quick Self-Assessment

See if you qualify for this Hackensack location

Preparing your pre-screening questions...

Expert Care in Hackensack

Access small cell lung cancer specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related small cell lung cancer treatment provided free

Apply for This Hackensack Location

Check if you qualify for this small cell lung cancer clinical trial in Hackensack, NJ

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Hackensack

    Convenient for NJ residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Hackensack site if eligible
  4. 4Begin participation

About This Small Cell Lung Cancer Study in Hackensack

This study aims to determine safety, tolerability, recommended phase 2 dose (RP2D), and preliminary antitumor activity of 225Ac-SSO110 with standard of care (SoC) therapy in patients with somatostatin receptor 2 expressing (SSTR2+) extensive-stage small cell lung cancer (ES-SCLC) and recurrent locally advanced or metastatic Merkel cell carcinoma (MCC).

Sponsor: Ariceum Therapeutics GmbH

Who Can Participate

Inclusion Criteria

Signed Informed Consent Form and willing to comply with all study procedures.
Participants with ES-SCLC (defined as Stage IV per NCCN guidelines Version 1.2024) or recurrent locally advanced or metastatic MCC (per NCCN guidelines Version 1.2024) documented by histology or cytology.
Participants eligible to receive immune checkpoint inhibitor (CPI) monotherapy at the start of treatment with 225Ac-SSO110 or patients already on CPI monotherapy for 7 weeks.
ECOG performance status of 0 or 1. Life expectancy of at least 6 months.
Positive 68Ga-SSO120 scan (Investigator-assessed) during screening. Key

Exclusion Criteria

Participants with unstable spinal cord compression.
Any previous systemic radioligand therapy or extensive radiotherapy.
Participants receiving or planned to receive consolidative chest radiation.
History of primary immunodeficiency, transplantation or CAR-T cell therapy.
Major surgical procedure except diagnostic biopsy within

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Hackensack?

Yes, this clinical trial (NCT06939036) has an active research site in Hackensack, NJ that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Small Cell Lung Cancer Treatment Options in Hackensack, NJ

If you're searching for small cell lung cancer treatment options in Hackensack, NJ, this clinical trial (NCT06939036) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Hackensack research site is actively enrolling participants for this clinical trial. You'll receive care from experienced small cell lung cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all small cell lung cancer clinical trials near you to find additional studies recruiting in your area.

More Lung Cancer Trials in Hackensack, NJ

See all lung cancer clinical trials recruiting in Hackensack — not just this study.

Browse Lung Cancer Trials in Hackensack

Ready to Join in Hackensack?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Hackensack, NJ